🌎 How can we expand access to precision medicine globally? Explore how the comprehensive SOPHiA DDM™ Platform can increase equity in access to care by expediting the implementation and adoption of accurate genomics testing in diverse, global populations. The SOPHiA DDM™ decentralized approach is accelerating precision medicine by helping pharma successfully implement their post-market strategies. 👉🏼Read our article on Sponsored Testing: https://loom.ly/47lGHgs #DataDrivenMedicine #PrecisionMedicine #Genomics #HealthEquity
Director | Biomedical Scientist at GMDL | Scaling Tech-Driven Clinical Labs | ISO 15189:2022 | Investing in Precision Diagnostics & Operational Excellence.
1dA great step toward making precision medicine more accessible worldwide! 🌍 The decentralized approach of SOPHiA DDM™ can truly bridge gaps in equity and bring advanced genomics closer to diverse populations. 👏